奥利戈-富科伊丹对社区老年人的肌肉功能的影响:双盲,随机,安慰剂受控试验
Yun-Ching Chang1, Hung-Wen Liu2, Tsung-Jen Hsieh1
1School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Archives of gerontology and geriatrics
|October 22, 2025
概括
在老年人中,Oligo-Fucoidan补充剂显著增强了肌肉力量和身体表现. 这项研究表明,富可伊丹可能是一种安全的,非药物治疗的选择,用于治疗肉症.
科学领域:
- 老年学和营养科学研究
- 海洋多糖的生物化学 海洋多糖的生物化学
背景情况:
- 随着年龄的增长,肌肉质量和功能的丧失,即萨尔科佩尼亚,是严重的健康问题.
- 对于具有有限运动能力的老年人来说,需要抵抗训练的替代干预措施.
- 来自棕色海藻的fucoidan显示出肌肉健康益处的潜力.
研究的目的:
- 研究Oligo-Fucoidan对老年人肌肉力量,质量和身体表现的影响.
- 评估Oligo-Fucoidan作为一种潜在的治疗肉症的干预措施.
主要方法:
- 一个为期12周的随机,双盲,安慰剂对照试验.
- 60名年龄≥60岁的参与者被分为三个组:Oligo-Fucoidan,Oligo-Fucoidan与BCAA和维生素D,或安慰剂.
- 结果包括握力强度,小腿周长,ALMI,5STS,6MWT和KE强度.
主要成果:
- 奥利戈-富科伊丹显著改善了握力 (p < 0.001) 和6MWT距离 (p < 0.001).
- 没有观察到肌肉质量的显著变化.
- 整体群体差异显著,主要是由于Oligo-Fucoidan组的握力改善.
结论:
- 在老年人中,Oligo-Fucoidan补充剂改善了肌肉力量和身体表现.
- 它显示出作为一种安全的,非药物干预的潜力,用于治疗肉症.
- 需要进一步的研究来评估长期影响和优化配方.
更多相关视频
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
4.3K
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.6K
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
224
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
224
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
01:19The Effect of Aging on Tissues
3.3K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.3K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
228
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
228
01:15Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222